Showing 161 - 178 results of 178 for search '"Boosterism"', query time: 0.07s Refine Results
  1. 161

    Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review by Mariana Herrera, Cristian Vera, Yoav Keynan, Zulma Vanessa Rueda

    Published 2020-01-01
    “…We found high heterogeneity between studies including failure to account for the time/illness of the individuals studied; varied samples and protocols; different clinical classification of TB; different laboratory methods for IP detection, which in turn leads to variable units of measurement and assay sensitivities; and selection bias regarding TST and booster effect. None of the studies adjusted the analysis for the effect of ethnicity. …”
    Get full text
    Article
  2. 162

    Treatment of e-cigarette use among hospitalised adolescents and young adults: a protocol for intervention development and evaluation of preliminary efficacy and implementation outc... by Delwyn Catley, Kimber P Richter, Karen Wilson, Shelbie Wooten, Melissa K Miller, Abbey Masonbrink

    Published 2025-01-01
    “…We will develop an evidence-based intervention that includes education, motivational interviewing, quit planning and nicotine replacement therapy prescription offered confidentially in person during the hospital stay and 4 weekly phone booster sessions. Control participants will receive brief advice and quit programme resources. …”
    Get full text
    Article
  3. 163

    Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer:... by Joachim G J V Aerts, Sjoerd H van der Burg, Martijn P Lolkema, Sai Ping Lau, Freek R van ’t Land, Marjolein Y V Homs, Casper H J van Eijck

    Published 2022-06-01
    “…This combination-immunotherapy regimen will be administered three times every 2 weeks, and booster treatments will be given after 3 and 6 months following the third injection. …”
    Get full text
    Article
  4. 164
  5. 165
  6. 166

    The effect of meningococcal vaccines on new generation of systemic inflammatory markers in children by Omer Okuyan, Neval Elgormus, Seyma Dumur, Ugurcan Sayili, Hafize Uzun

    Published 2025-01-01
    “…In this study, in order to support the appropriate use of various MVs in the prevention of meningococcal meningitis (MM), the effects of MVs, especially single-dose and inter-booster administered, on inflammatory parameters in < 5-year-old children were investigated. …”
    Get full text
    Article
  7. 167

    Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus by Xuchang Shan, Ruiwen Han, Xueting Cheng, Jialuo Bing, Zhenyong Qi, Shucai Sun, Tangqi Wang, Qiaohong Chu, Yao Deng, Desheng Zhai, Wenjie Tan

    Published 2025-01-01
    “…Then, we evaluated the effects of the immune response and protection of this mRNA vaccine in mice up to 24 weeks post-vaccination. Following booster immunization, robust and long-lasting RSV pre-F-specific IgG antibodies were detected in the serum of mice, which exhibited Th1/Th2 balanced IgG response and cross-neutralizing antibodies against different subtypes (RSV A2, B18537, and clinical isolate hRSV/C-Tan/BJ 202301), with a clear dose–response relationship observed. …”
    Get full text
    Article
  8. 168

    A machine learning model to predict the risk factors causing feelings of burnout and emotional exhaustion amongst nursing staff in South Africa by Maria Magdalena Van Zyl-Cillié, Jacoba H. Bührmann, Alwiena J. Blignaut, Derya Demirtas, Siedine K. Coetzee

    Published 2024-12-01
    “…Results The gradient booster classifier (GBC) model had the highest accuracy score for predicting both self-reported feelings of burnout (75.8%) and emotional exhaustion (76.8%) from full survey data. …”
    Get full text
    Article
  9. 169

    Effect of Spine Nerves Muscle Stimulation Combined with Scalp Acupuncture on Shoulder-hand Syndrome after Early Stroke by Huazhong YANG, Yongsheng ZHOU, Haipeng JIA, Qingjun YANG, Lingjuan RAO

    Published 2019-06-01
    “…The control group was treated with scalp acupuncture(The scalp movement area was needled and the midline of the vertex, anterior and posterior oblique line of the parietal of the healthy side were located according to the brain functional area)combined with conventional physiotherapy(included passive joint activity, neural booster and neuromuscular electrical stimulation therapy), 2 hours and 45 minutes per day, 5 days per week. …”
    Get full text
    Article
  10. 170

    Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial by Jelena Tica, Veronica V. Rezelj, Benoit Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, Gert Scheper, Mathieu Le Gars, Frank Struyf, Macaya Douoguih, Javier Ruiz-Guiñazú

    Published 2025-12-01
    “…Adolescents who received a 1-dose primary schedule received a 2.5 × 1010 vp booster dose 6 months later. Safety and humoral immunogenicity were assessed up to 6 months post-last vaccination. …”
    Get full text
    Article
  11. 171
  12. 172

    The effectiveness of providing training and ongoing support to foster cultural humility in volunteers serving as mentors to youth of color: a mixed-methods study protocol by Bernadette Sánchez, Amy J. Anderson, Carla Herrera, David L. DuBois, Kay Thursby Bourke, Jean K. Sack, So Jung Lee, Karen Burchwell, Lidia Y. Monjaras-Gaytan, Yesenia Garcia-Murillo

    Published 2025-01-01
    “…., approximately 3 h of initial training that is then supplemented with booster emails and in the context of the contacts that case managers have with mentors routinely in the program). …”
    Get full text
    Article
  13. 173

    Tick-borne encephalitis vaccination in persons with a recent history of Lyme borreliosis: Insights from a Knowledge, Attitudes and Behaviour survey in Bavaria, Germany by Stefanie Böhm, Andreas Beyerlein, Volker Fingerle, Merle M. Böhmer, Manfred Wildner

    Published 2025-03-01
    “…Of 228 participants who provided further details, 142 (62 %) reported to have received a regular booster vaccination. Apart from age category and TBD-specific knowledge level, vaccination status was not associated with any other sociodemographic or residence-specific factors, outdoor behaviours, occupational exposure, or prior experiences with ticks or TBDs. …”
    Get full text
    Article
  14. 174
  15. 175

    Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocol by Iuno Z. Groot, Anne-Sophie S. M. Venhuizen, Nathan Bachrach, Simone Walhout, Bregje de Moor, Kasper Nikkels, Susanne Dalmeijer, Myrte Maarschalkerweerd, Joël R. van Aalderen, Hinde de Lange, Renske Wichers, Agatha Ph. Hollander, Silvia M. A. A. Evers, Raoul P. P. P. Grasman, Arnoud Arntz

    Published 2022-10-01
    “…Assessments take place at week 0 (baseline), 17 (mid-GST), 34 (post-GST), 51 (post-booster sessions of GST), and 2 years (FU). Patient characteristics predicting better response to a specific treatment are studied, e.g., childhood trauma, autistic features, and introversion. …”
    Get full text
    Article
  16. 176

    Risk of SARS-CoV-2 infection before and after the Omicron wave in a cohort of healthcare workers in Ontario, Canada by Jorge L. Martinez-Cajas, Ann Jolly, Yanping Gong, Gerald Evans, Santiago Perez-Patrigeon, Bradley Stoner, T. Hugh Guan, Beatriz Alvarado

    Published 2025-02-01
    “…In period #2, the hazard of infection was higher among HCWs who had COVID-19-infected children at home, whereas the use of protective measures in the community (maintaining social distance, mask-wearing) and receiving a vaccine booster were associated with reduced risk. Providing care to COVID-19 patients was not associated with the risk of acquiring SARS-CoV-2 infection at period #2. …”
    Get full text
    Article
  17. 177

    Comparison of Long-Term Antibody Titers in Calves Treated with Different Conjunctival and Subcutaneous <i>Brucella abortus</i> S19 Vaccines by Ali Uslu, Zafer Sayın, Aslı Balevi, Yasin Gulcu, Fırat Ergen, Islam Akıner, Oguzhan Denizli, Osman Erganis

    Published 2025-01-01
    “…In this study, a total of 115 calves aged 3 to 4.5 months were created in five groups, with 23 animals in each group: group 1 (vaccine brand A), group 2 (vaccine brand B), and group 3 (vaccine brand C) received the two-dose conjunctival vaccine, group 4 received the single-dose subcutaneous vaccine (vaccine brand C), and group 5 received the subcutaneous vaccine (vaccine brand C) plus the booster dose conjunctival vaccine (vaccine brand B). …”
    Get full text
    Article
  18. 178

    Improvement and exploration of a water conservation system in the Central Sterile Supply Department (节水型消毒供应中心给水系统改进与探索) by WANG Yuena (王岳娜), REN Guquan (任顾群), LIU Jianrong (刘建荣), XU Yuanle (许远乐), RENG Xiajuan (任娟霞), MA Huan (马欢)

    Published 2024-11-01
    “…Once recovery requirements are met, the water pipes were modified to recover the concentrated water for storage, and the booster pump was used to pipeline the concentrated water to the water consuming point. …”
    Get full text
    Article